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Abstract 
Introduction: A programme of rehabilitation using auditory cues has previously been shown to decrease 
movement variability in the gait of Parkinsonian patients. 
Objective and methods: We studied the temporal variability of finger-tapping and gait in 9 patients 
with Parkinson's disease (PD) before and after they undertook a physical rehabilitation programme. Positron 
Emission Tomography (PET) using 2-deoxy-2[18F]fluoro-d-glucose (FDG) was performed in these subjects to look 
for changes in metabolic brain activity after completion of the rehabilitation program. 
Results: The reduction of variability was seen not only in gait but also other repetitive movements such as finger 
tapping. Furthermore, here we show differences in resting regional cerebral glucose utilisation in these patients 
compared to healthy controls (significant hypometabolism—p<0.001—for the PD group in the right parietal and 
temporal lobes, left temporal and frontal lobes and a hypermetabolism in the left cerebellum) and specific changes 
following the improvements in repetitive movement abilities (significant metabolic increment—p<0.001—in the PD 
group in the right cerebellum and in the right parietal and temporal lobes). 
Conclusions: Although our study does not allow us to draw firm conclusions, it provides new information on the 
neural basis of auditory stimulation in PD. Our results extend those from previous studies to show improvement in 
the temporal variability of two types of rhythmic movements after participation by PD patients in a physical 
rehabilitation programme, along with changes in glucose uptake in several brain areas involved in sensorimotor 
processing. 
Keywords: Rehabilitation; Parkinson; PET; Finger tapping; Gait; rhythm 
1. Introduction 
Parkinson's disease (PD) is clinically characterized by the association of akinesia, rigidity, and 
resting tremor related to a dopaminergic deficiency of the nigrostriatal pathway. Although patients with 
PD commonly show slowness and hypometria regarding motor performance, disrupted behaviours that 
depend upon precise timing, such as rhythmic movement may also be observed. As noted by Stelmach 
and Worringham [1], timing is a primary aspect of any movement and patients with PD show deficits in 
the regulation of either force and time parameters, rather than, simply, in force production. Nakamura and 
colleagues reported that patients had difficulty in maintaining rhythmic movements, such as finger 
tapping [2], and Hausdorff and colleagues showed that the ability to maintain a steady gait (i.e. low 
stride-to-stride variability of gait cycle timing and its sub-phases) was diminished in PD (therefore 
showing high stride-to-stride variability) and the degree of gait variability correlated with disease 
severity [3]. On the other hand, patients with PD often also exhibit a strong dependence on external cues. 
There are several examples in support of this: periodic visual inputs from a striped pattern on the floor or 
a staircase can help PD to sustain locomotion [4], [5] and [6], while in the absence of visual cues patients 
showed a impairment in the performance of sequential movements [7] and [8]. Furthermore, finger-
tapping performance was improved in presence of auditory external cues [9]. 
This dependence on external cues to execute repetitive rhythmic movements has led to a number of 
intervention strategies in physical therapy designed to improve parkinsonian repetitive movements. 
Successful examples are rhythmic auditory stimulation (RAS) [10], the metronome therapy [11], and a 
physical rehabilitation programme (PRP) consisting of a variety of motor tasks performed in combination 
with rhythmic sound with different cadences [12]. However, research data are yet inconclusive as 
how sensorimotor facilitation can improve brain function and, what is the nature of the underlying 
mechanisms of recovery. 
A number of studies have examined cerebral blood flow changes associated with performance of 
motor tasks in patients with PD [13], [14] and [15]. These have shown impairments at the levels of 
the supplementary motor area (SMA) and the dorsolateral prefrontal cortex (DLPFC). However, the 
lateral premotor system, which is involved in externally triggered movements, seems not to be impaired 
in PD [14]. While SMA and DLPFC receive a major subcortical input from the basal ganglia, the lateral 
parietal and premotor areas are targeted by cerebellar projections and are thought to preferentially 
facilitate instructed rather than freely chosen movements [16]. Interestingly, it has been shown that this 
circuit is overactivated in PD when patients perform sequential finger movements with one or both 
hands [17] and [18]. The ability of PD patients to overactivate these lateral cortical areas may explain 
why they are better able to perform external cued as opposed to freely chosen actions [19]. 
The purpose of this study was two fold: firstly, following on from a previous study in our 
laboratory [12], we examined the temporal variability of finger-tapping and gait in patients with PD 
before and after they undertook our physical rehabilitation programme. Secondly, we used positron 
emission tomography (PET) using 2-deoxy-2[18F]fluoro-d-glucose (FDG) in these subjects to look for 
changes in metabolic brain activity after completion of the Rehabilitation Program. 
2. Patients and methods 
2.1. Subjects 
A total of 14 subjects were successfully recruited for this study, comprising nine patients with 
idiopathic PD (five men and four women, aged 61.2±5.22) and five age-matched control subjects (two 
men and three women, aged 63.1±4.28) with no history of neurological disorders. All subjects provided 
informed consent according to the Declaration of Helsinki (1964). PD patients were excluded if they had 
musculoskeletal, cardiovascular or visual disturbances that affected walking ability, or a score <20 on the 
short test of mental status [20], excluding the co-existence of significant dementia. A fundamental 
requirement for being included in the study was the ability to walk five times up and down a 30 m 
walkway without walking aids or assistance. For PD patients the level of functional disability was also 
determined by the mean of the unified parkinson's disease rating scales (UPDRS) [21], and the Hoehn and 
Yahr scale [22]. Table 1 shows the specific characteristics of the PD group. All patients showed clinical 
asymmetry. Four Parkinson's disease patients had an akinetic-rigid phenotype, and five patients had 
a tremor-dominant phenotype. Drug treatment was kept unchanged throughout the study. 
Table 1. Demographic and clinical data of PD patients and control subjects 
Patient Age Years since diagnosis Phenotype Laterality Stms Hoehn and yahr Schwab and England (%) Updrs 
         
1 (F) 64 6 Akinetic Right 25 2 90 26 
2 (F) 62 6 Tremor Right 25 1 90 23 
3 (M) 68 8 Tremor Left 31 2 90 33 
4 (F) 65 8 Tremor Right 33 2.5 80 45 
5 (M) 65 5 Tremor Right 30 2 90 28 
6 (F) 54 8 Akinetic Right 30 2.5 90 42 
7 (M) 65 4 Akinetic Right 27 2 90 27 
8 (M) 53 4 Tremor Right 33 1 90 12 
9 (M) 55 3 Akinetic Left 32 2 90 32 
         
Control Age Dominant hand 
         
1 (F)   65   Right   
2 (F)   67   Right   
3 (F)   66   Right   
4 (F)   63   Right   
5 (F)   55   Right   
         
 
Phenotype, akinetic-rigid, or tremor-dominant; laterality, side of body that is most affected by Parkinson's disease; M, male; F, 
female; STMS, short test of mental status; UPDRS, unified parkinson's disease rating scales.  
2.2. Procedure 
Firstly, both PD and control groups were evaluated in the basic motor tasks as described below. The 
following day each subject was evaluated by PET. After this, the PD group began the physical 
rehabilitation programme. All treatment sessions lasted 1 h per day, five days a week for 4 weeks. The 
aim of this programme was to improve (minimize) the temporal variability of finger tapping at preferred 
diadochokinesis rate (Comfort) and the temporal variability of gait at preferred speed in Parkinson's 
disease patients. To improve the temporal stability of the finger tapping new exercises were attached to 
the original physical rehabilitation programme described in the first work [12]. All movements were 
performed under two different conditions; in the presence of rhythmic auditory cues (synchronized task) 
or without auditory cues (reproduction task) but patients were never asked to perform the finger-tapping 
or gait tests (this means at preferred frequency) during the programme (i.e. no direct training in the test 
tasks). The program included the following exercises: 
 
(1) Gait without upper limbs movements—e.g. patients were asked to walk reproducing or in synchrony 
with a rhythmic auditory signal.1 
 
(2) Gait with sequential movements of the upper limbs—e.g. patients were asked to walk reproducing or 
in synchrony with a rhythmic auditory signal1 while touching themselves on different parts of the 
body, always in the same order. 
 
(3) Gait with upper limb rhythmic repetitive movements—e.g. patients were asked to walk reproducing or 
in synchrony with a rhythmic auditory signal1 while repetitively apposing thumb to index finger with 
one hand. 
 
(4) Gait with upper limbs bimanual movement—e.g. patients were asked to walk reproducing or in 
synchrony with a rhythmic auditory signal1 while manipulating an object with two hands. 
 
(5) Gait with upper simultaneous movement—e.g. patients were asked to walk reproducing or in 
synchrony with a rhythmic auditory signal1 while bowling a basketball. 
 
(6) Repetitive single movements with a one arm. Patients were asked to oppose the index finger to the 
thumb reproducing or in synchrony with a rhythmic auditory signal.2 
 
(7) Repetitive sequential movements with a one arm. Patients were asked to oppose the thumb to the other 
fingers reproducing or in synchrony with a rhythmic auditory signal.2 
 
(8) Repetitive bimanual movements (two arms single movement). Patients were asked to tap with both 
arms reproducing or in synchrony with a rhythmic auditory signal.2 
 
(9) Repetitive bimanual movements (two arms sequential movement). Patients were asked to tap the table 
with each finger in sequence reproducing or in synchrony with a rhythmic auditory signal.2 
 
When the physical therapy was completed the PD group was re-evaluated (in both motor tasks and 
PET). The patients were always examined at the peak dose effect of their antiparkinsonian medication 
(ON phase). Controls were evaluated once only and did not undertake the rehabilitation programme. 
2.3. Evaluation conditions 
2.3.1. Gait parameters 
For evaluation, all subjects walked along a 30 m flat walkway. The instruction to the subject was 
simply to ‘walk to the end of the walkway, at your preferred speed’. This is called preferred gait. To 
measure the temporal and spatial parameters of the footstep pattern, a set of switches was worn as insoles 
inside the shoes, sending data in real time (sampling rate 1 m s) by mean of a small radio transmitter 
(10×5×2 cm), to a radio receiver connected to a computer. The system was also connected to two pairs of 
photoelectric cells, one placed at the beginning and one at the end of the walkway. 
The dependent variables measured for each condition of gait included: velocity (m/min); step length 
(m); cadence (steps/min) and the coefficient of variation (CV) of recorded intervals between two 
consecutive steps (in ms). CV is an indicator of temporal variability of gait, where CV=(Standard 
deviation/mean)×100.  
2.3.2. Finger tapping test 
All participants performed repetitive flexion-extension movements with their index finger. Subjects 
were asked to tap at their preferred diadochokinesis rate (Comfort) for a period of 30 s. Tapping was 
performed with the index finger on the more affected side. If both sides showed similar condition in 
bilaterally affected patients, they were allowed to use the finger of the dominant hand. A flexible metal 
loop was fitted snugly to the index finger just proximal to the terminal interphalangeal joint. Each time 
the metal loop on the index finger struck the contact plate it completed an electrical circuit and generated 
a brief voltage pulse. Subjects were seated with their forearms resting on a support (elbow angle about 
90°). To prevent wrist flexion/extension, the wrist was immobilised by a cast. This procedure assured that 
the sequencing task could be accomplished only by a tapping motion of the index finger. 
The dependent variables that were measured for each condition of finger tapping included the tapping 
frequency in Hz and the coefficient of variation (CV) of interval of two consecutive taps (in ms) as a 
indicator of temporal variability of tapping. 
2.4. Statistical analysis 
Results were analysed by paired t test (between PD patients before and after Physical Rehabilitation 
Programme) and by two sample t test (between PD patients and control group). 
2.5. PET scanning procedure 
FDG-PET scans were performed on high-resolution PET camera (ECAT EXACT 47; Siemens, 
Erlange, Germany, axial field of view 16.2 cm, in-plane resolution 5 mm with a half maximum in the 
centre of the field of view), 28 min after intravenous injection of a mean of 185 MBq of FDG. Prior to the 
study, a 68Germanium–68Gallium transmission scan was performed for 5 min to correct the attenuation. 
All FDG-PET studies were performed with the subjects eyes closed in a darkened room with minimal 
noise. Adjustable leather straps were used to minimize movement while ensuring the participant's comfort 
and laser settings in each scan. The number of scans for patient was two (before and after the physical 
programme) and one for the control subjects. 
2.5.1. Data analysis 
The images were analysed using statistical parametric mapping (SPM2; Wellcome Department of 
Cognitive Neurology, London, UK) implemented in Matlab (Mathworks, Inc., Natick, MA, USA). In 
SPM2 the images were first realigned and co-registered to each other. They underwent spatial 
normalization, which aligns and warps the individual images into a standard reference space. The data 
were smoothed using a Gaussian filter (16-mm) to reduce error variance due to image noise and small-
scale differences in functional and gyral anatomy. Proportional scaling was used to adjust for differences 
in global activity between scans. Effects were estimated according to the General Linear Model at each 
and every voxel. Thus a single average image was produced for each group and images show voxels of 
significant Z score overlayed onto a standard Talairach MRI-derived brain model, using SPM2. Two 
types of statistical analysis were performed: comparisons between the PD patient and control groups (two 
sample t-test) and comparisons between the PD patient group scanned pre- and post-Physical 
Rehabilitation Programme (paired t-test). Each comparison gave both significant positive and negative 
results, each of which are reported here. Results are reported at a threshold of Z>3.70 (p<0.0001, 
uncorrected) for structures without a priori hypothesis. Anatomical locations were identified according to 
the atlas of Talairach and Tournou [23]. 
3. Results 
3.1. PD group before therapy vs control group 
Table 2 shows the mean values for step length, cadence, velocity, coefficient of variation of gait in 
the Parkinson's disease group compared with control group. The cadence and coefficient of variation of 
finger tapping are also shown. The coefficients of variation for gait and finger tapping were significantly 
higher in the Parkinson group (t=3.245 p<0.01 and t=2.483 p<0.05, respectively). From the rest of 
parameters evaluated there was only a significant difference for velocity of gait, which was less for the 
PD group (t=2.904 p<0.05).  
Table 2. Comparison between patients before and after the physical rehabilitation program and control subjects 
Parameter Pd Control 
 Before After  
Gait    
Velocity (m/min) and  70.79 (6.52) 69.97 (6.88) 80.60 (4.98) 
Cadence (steps/min) 110.99 (7.91) 109.33 (10.06) 117.05 (2.71) 
Step length (m) 0.63 (0.06) 0.64 (0.06) 0.69 (0.05) 
Coefficient of variation and  6.98 (3.61) 4.17 (2.76) 2.76 (1.08) 
Finger tapping    
Frequency (Hz) 2.55 (1.16) 1.81 (0.62) 1.67 (0.50) 
Coefficient of variation and  14.80 (12.79) 6,39 (3.02) 4,16 (0.86) 
    
 
Means and standard deviations. The superscript letters show statically significant differences between: 
a PD before the physical rehabilitation and control subjects. 
b PD after the physical rehabilitation and control subjects. 
c PD before and after the physical rehabilitation. 
Using PET we detected a significant hypometabolism for the PD group in the right parietal and 
temporal lobes (z=4.42 p<0.001), left temporal lobe (z=4.38 p<0.001), left frontal lobe (z=4.00 p<0.001) 
and a hypermetabolism in the left cerebellum (culmen of anterior lobe, z=3.74 p<0.001) ( Table 3 
and Fig. 1). 
Table 3. PD group before therapy vs control group 
Areas BA L/R Z a score Coordinatesb 
    x y Z 
       
Temporal lobe 21 L −4.38 −66 −38 −6 
Middle temporal gyrus       
Parietal lobe 39 R −4.42 50 −58 26 
Temporal lobe       
Superior temporal gyrus       
Supramarginal gyrus       
Frontal lobe 10 L −4.00 −26 50 8 
Sub-gyral       
Middle frontal gyrus       
Superior frontal       
Anterior cerebellum lobe  L +3.74 −10 −44 −8 
Culmen       
       
 
a Table Negative values of the Z score show reductions in glucose metabolism in Parkinson's disease patients compared to normal 
subjects. Positive values of Z show hypermetabolism in Parkinson's disease patients compared to normal subjects. 
b Converted to Talairach space. BA, Brodmann's area; L, left; R, right. 
3.2. PD group before vs PD group after therapy 
Upon completion of the 20 session program, PD subjects demonstrated a statistically significant 
decrement in the coefficient of variation obtained for finger-tapping and gait (t=2.107 p<0.05 and t=3.887 
p<0.01, respectively). The new values of CV recorded for the patients did not statistically differ from 
those obtained for control subjects ( Fig. 2). However, the rest of the observed parameters did not show 
any significant change in the PD subjects at the end of the programme ( Table 2).  
 
 
Fig. 1. Location of areas of the brain where there was significant abnormal glucose uptake in Parkinson's disease patients compared 
to normal subjects. (A)–(C) show a significant hypometabolism in PD patients. (D) show a significant hypermetabolism in PD 
patients. A: left temporal lobe B: right temporal lobe, right parietal lobe, right superior temporal gyrus; C: left frontal lobe, left sub-
gyral, left middle frontal gyrus, left superior frontal gyrus; D. Left anterior cerebellar lobe, culmen. 
 
 
Fig. 2. The coefficient of variation in the PD patients decreased significantly after therapy for finger tapping task (left) and for gait 
(right). Before therapy the coefficient of variation in PD patients was significantly higher than control subjects. After therapy the 
coefficient was not significantly different from controls but was significantly different from pretraining levels both for finger 
tapping and gait. 
  
Table 4. FDG-PET Data. PD group before vs after therapy 
Areas BA L/R Z a score Coordinatesb 
    x y Z 
       
Temporal lobe 22,42,43 R +4.58 64 −12 14 
Parietal lobe       
Transverse temporal gyrus       
Postcentral gyrus       
Anterior cerebellum lobe Dentate nucleus  R +4.38 6 −48 −36 
       
 
a Table Positive values of Z show increased metabolism in Parkinson's disease patients after physical therapy compared with before 
physical therapy. 
b Converted to Talairach space. BA, Brodmann's area; L, left; R, right. 
 
 
Fig. 3. Location of areas of the brain where there were significant changes in glucose uptake between PD patients before and after 
therapy. (A) and (B) show a significant increase in PD patients after therapy. A: right parietal lobe, right temporal lobe, 
right transverse temporal gyrus, right postcentral gyrus; (B): cerebellar lobe, right dentate nucleus. 
4. Discussion 
Following on from our recent study [12], here we present further evidence that our PRP enhances the 
ability of PD patients to perform repetitive motor tasks, using a regime of training over a 1 month period. 
The data now not only show this in the case of variability of gait in a walking test, but also for finger 
tapping. Further, we now demonstrate concomitant changes in cerebral glucose utilisation using FDG in a 
PET paradigm, comparing activity before and after. 
4.1. PD group before therapy vs control group 
In our experiment, PD patients showed greater variability than control subjects in the motor tasks 
under study, finger tapping and gait. These results are in agreement with previous work by ourselves and 
others and confirm the difficulty that patients with Parkinson's disease have to maintain a rhythmic 
movement. Temporal variability in the finger-tapping test in patients with PD has been previously 
demonstrated in various studies [2], [24] and [25] including those with patient receiving dopaminergic 
replacement therapy [26]. More recently the temporal variability in gait was reported by Hausdorff and 
colleagues [3], and ourselves [12], and the irregular timing of steps in PD suggests a disturbance of the 
rhythmic locomotor activity generation [27]. Our results show that the patient group had a significantly 
slower velocity compared with the control group, in agreement with previous studies by 
others [12], [28] and [29], even though the step length and the cadence were not significantly different 
between patients and control subjects. 
When compared to control subjects, the PET analysis showed that PD patients exhibited a significant 
hypometabolism in the right and left temporal lobes, right parietal lobe and left frontal lobe, and a 
hypermetabolism in the cerebellum (left side, culmen of anterior lobule). Previous FDG-PET studies in 
non-demented patients with Parkinson's disease have produced conflicting results. The studies of 
Eidelberg and collaborators [30] and [31] by the scaled sub-profile model (a method based on principal 
component analysis of region-of-interest (ROI) data) have led to a characteristic metabolic profile in 
Parkinson's disease, the so-called ‘Parkinson's disease-related profile (PDRP)’, which comprises a relative 
hypermetabolism in the lentiform nucleus, thalamus, and pons, covarying with a relative hypometabolism 
of the lateral frontal cortex. Furthermore, a positive correlation was reported between this profile 
and bradykinesia scores, such that the more severe the bradykinesia the more marked the PDRP [31]. 
However, studies using the ROI method leave substantial areas of the brain unexplored, and have limited 
reproducibility and objectivity, and often merge physiologically distinct structures into a single value, 
(e.g. putamen and globus pallidus), potentially obscuring important findings [32]. Furthermore, these 
studies were performed when patients were in their OFF state, with antiparkinsonian medication at its 
least effective [32]. Interestingly, Berding and colleagues found significant correlations in advanced 
patients with PD between increasing UPDRS scores and decreases in FDG uptake in both frontal cortices 
and the medial temporal lobe on the right side in the ON state, whereas no correlation was found in the 
OFF state [33]. In another study, a bilateral decrease in glucose uptake was found in parietal and temporal 
cortices in non-demented patients [34]. Our results, with hypometabolism in the frontal and temporal 
lobes, are in agreement with the above mentioned studies [33] and [34], and our patients were always 
evaluated in the ON state. However, we have not calculated possible correlations between glucose uptake 
and clinical scores in the present study. The small number of patients and both, the absence of remarkable 
end of doses effects, and on–off fluctuations, would render underpowered this approach. 
We also found hypermetabolism in the cerebellum (midline to left, anterior lobe) in our patient group. 
The meaning of this result is more difficult to explain. The nigrostriatal pathway and the cerebellum 
appear to be involved in resting tremor [35]. In fact, several PET studies of PD patients with deep brain 
stimulation in the ventral intermediate nucleus of the thalamus or in the globus pallidus (GPi) have shown 
increased glucose uptake in the cerebellar vermis in presence of tremor and a decrease in the absence of 
tremor [36], [37] and [38]. On the other hand, however, it has been reported that glucose uptake of the 
cerebellar vermis showed a significant negative correlation with the tremor, such that the more severe 
tremor the lower the vermian metabolism [32]. Hilker and coworkers [39], compared the effect of high-
frequency stimulation of the subthalamic nucleus (STN) and a levodopa-challenge on cerebral metabolic 
activity by FDG-PET in a single patient and found a marked decrease of regional cerebral metabolic rate 
of glucose in the rostral cerebellar hemispheres in the STN-on-condition (with an important, concomitant 
decrease of tremor), while the inferior vermis showed an increase of glucose consumption. This 
discrepancy may be due to different types of afferent cerebellar input. Furthermore, recent views posit 
that in preventing the resting tremor from spilling over into voluntary movement, the cerebellum may 
have a compensatory rather than a causal role in PD and the observed tremor-related hyperactivity may be 
related to the cerebellum actively limiting the rhythmic activity produced by the basal ganglia [37]. It is 
important to note that, like the physiological studies, these PET studies were carried out during the peak 
of activity of the antiparkinsonian medication for each patient. 
4.2. PD group before vs PD group after therapy 
In our hands, PD patients improved the regularity of timing in both movements evaluated; this is, 
finger tapping and gait. Thus, the interval time between taps and between steps became more regular, 
following therapy (we should emphasise, however, that our study is a pre-post design and we did not 
include a control patient group which did not receive therapy). This finding agrees with previous studies 
where walking exercises in the presence of a rhythmic auditory stimulus (RAS) carried out by patients 
with PD have been shown to be an effective way to improve the temporal pattern of the electric activation 
in certain muscles, not seen in the absence of the auditory cue [40] and [41]. Although our training 
paradigm did not improve other parameters like the cadence, velocity or stride length, in other studies 
patients with PD were able to improve the velocity of their movements after continued practice [42]. This 
is thought to be an important change since it has been shown that the ability to regulate the stride-to-stride 
variation in gait timing is impaired in Parkinson's disease patients with freezing of gait compared to those 
without freezing of gait [43]. In this sense, measurement of gait variability might have a clinical value as 
a predictive parameter. Furthermore, as suggested by Hausdorff and co-workers the stride-to-stride 
variability in stride time will likely reflect an important aspect of the stride-to-stride control of gait, 
generally, and stride length, in particular [43]. 
Finger tapping as a task was chosen as a simple reproducible model for repetitive actions (like gait), 
which could easily be tested under many different conditions. The work we now report extends our recent 
observations [12], and suggests that finger tapping might be an alternative task to examine movement 
variability. The improvement in the temporal variability that we observed in finger tapping after the 
therapy, supports the idea that walking and finger tapping share many of the same characteristics (being 
seemingly automatic, periodic) and are regulated by many of the same neural networks (such as basal 
ganglia, cerebellum) [44] and [45]. 
With regard to the PET analysis, our results show an increased glucose uptake in the right anterior 
lobule of the cerebellum and dentate nucleus near the midline and in the right temporo-parietal 
conjunction after therapy. This increase, together with the improvement in the motor task in our patients 
after therapy, might mean access to an alternative pathway to compensate the damage to the basal ganglia 
via SMA to prefrontal circuit, by means of cerebellar projections. While the SMA and DLPFC receive a 
major subcortical input from the basal ganglia, the lateral parietal and premotor areas are targeted by 
cerebellar projections. However those projections from cerebellum to cerebral cortex are thought to be 
mainly contralateral and the activity increase we have shown is ipsilateral. However, dynamic PET 
studies during the performance of free joystick movements in patients with PD have shown not only a 
decrease in the activity of supplementary motor area (SMA) and dorsolateral prefrontal cortex (DLPFC), 
(this is, in the pathway from basal ganglia via SMA to prefrontal cortex), but also increased activity in the 
cerebellar to parietal to premotor cortex pathway, when this movements was externally 
triggered [19] and [46]. Thus this pathway could be an adaptive behaviour to dopaminergic deficit and 
explain why patients with PD improve their movement in presence of external cues [17] and [47]. 
Although our protocol lacks a control group without training, it is tempting to speculate that this might 
also include work in this study using external cues in training since it is necessary to remember that our 
study was a simple examination of resting glucose utilisation, without motor task. We suggest that this 
activity of the cerebellum, and through it the parietal and premotor areas, would be further increased in 
the presence of cued movements. Thus the finding that a movement such as finger tapping may improve 
during our training will permit future works to examine this protocol during dynamic imaging studies. 
In the light of our results we cannot to assert that the improvement in timing in our patients after 
therapy was only due to motor mechanisms but perceptive mechanism too. 
Wing and Kristofferson [48] and [49] proposed a two-process model of the analysis of the timing of 
repetitive movements. In this model two independent processes are assumed to be involved in timing. The 
first is an internal timekeeper, which triggers the response and so determines when a response should be 
made, and the second is an implementation system, which executes the motor command. The basal 
ganglia and cerebellum have been logical candidates for hypothetical timekeeping operations, as damage 
to these brain regions commonly disrupts behaviours that depend upon precise timing, (such as rhythmic 
movements in Parkinson's disease [50]) and regulation of agonist-antagonist muscle activity in cerebellar 
damage [51]. Furthermore, a recent study of used functional MRI provides compelling evidence for the 
involvement of the basal ganglia in formulating representations of time [52]. Our results did not show an 
increase in glucose utilisation in the basal ganglia after therapy but did in the dentate nucleus and in the 
right temporal and parietal lobes. The dentate nucleus is also thought to be involved in timekeeping 
mechanism [24], [53], [54] and [55] and the inferior right parietal and superior temporal cortex are 
involved in the coding of temporal intervals [52], [56] and [ 57]. Thus it is possible to suggest that the 
main adaptation in our patients after therapy would be related to timekeeping more than any 
motor/effector system. It is important to underline that the all movements performed by the patients 
during therapy demanded continuous coding of temporal intervals, for the rhythmicity of these 
movements was always imposed externally by auditory cues under experimental control rather than 
internally by the patient. 
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